Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 10:45:38 - browse：397

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FTC loses bid to block Novant's North Carolina hospital merger

focus

WSS

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Welsh Carson private equity firm escapes from FTC antitrust case

The effects of a landmark ruling on DNA ownership are becoming clearer

Class action alleges UnitedHealth concealed DOJ probe

Can gargling with Listerine treat gonorrhea of the mouth?

Senators tussle over abortion against the backdrop of a presidential campaign

focus

Wikipedia

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Brain technologies pose threats that are all too real, experts warn

Sports medicine is finally prioritizing gender equality

Take antibiotics after sex, CDC recommends for certain risk groups

Medical records are filled with copy

For pregnant people, addiction treatment shouldn't mean a call to child protective services

In age of alternative facts, a scholarly course on calling out crap

CMS got Medicare Advantage quality rating wrong, judge rules

Cancer drug shortages should be causing more outrage

How CO2 helps viruses stay alive longer in the air

focus

As billionaires fund anti

As health system earnings go up, health insurance stocks go down

Deliver public health messages at the right time

Welsh Carson private equity firm escapes from FTC antitrust case

BIO to announce reorganization, senior leaders expected to depart

FDA approves Moderna’s RSV vaccine, its second licensed product

explore

focus

focus

hotspot